Randy H. Weiss
Nessuna posizione attualmente
Profilo
Randy H.
Weiss is the founder of Cardialen, Inc. (founded in 2008), Euclises Pharmaceuticals, Inc. (founded in 2011), and SARmont LLC (founded in 2010).
At SARmont LLC, he held the title of President & Chief Executive Officer.
Dr. Weiss's former jobs include Chief Executive Officer & Director at Arch Oncology, Inc. in 2011 and Partner at Triathlon Medical Venture Partners LLC.
Dr. Weiss's education includes an MBA and doctorate from Washington University in St. Louis and an undergraduate degree from Southeast Missouri State University.
Precedenti posizioni note di Randy H. Weiss
Società | Posizione | Fine |
---|---|---|
Euclises Pharmaceuticals, Inc.
Euclises Pharmaceuticals, Inc. Hospital/Nursing ManagementHealth Services Euclises Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm develops a portfolio of COX-2 inhibitors optimized for cancer treatment based on its proprietary Euclicoxib platform and is in the process of selecting a lead clinical development candidate. The company was founded by John J. Talley in 2011 and is headquartered in St. Louis, MO. | Fondatore | - |
Cardialen, Inc.
Cardialen, Inc. Medical SpecialtiesHealth Technology Cardialen, Inc. develops medical devices. It offers pain-free cardio version therapy for atrial fibrillation (AF) using low-energy implantable atrial cardioverters. The firm develops and commercializes these as an independent specialist, to address major needs in atrial fibrillation management, achieve improved outcomes and reduce the risk of stroke, heart failure and high healthcare costs associated with atrial fibrillation. The company's products comprise implantable low-energy pain-free atrial cardioverters and cardiac leads and defibrillator equipment. Its products are used for the treatment of atrial and ventricular arrhythmias. Cardialen was founded in 2008 by D. Graeme Thomas, Randy H. Weiss and Igor R. Efimov and is headquartered in St. Louis, MO. | Fondatore | - |
Arch Oncology, Inc.
Arch Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Arch Oncology, Inc. develops drugs for life-threatening disorders. Its products include anti-CD47 monoclonal antibody, CD47 antisense oligonucleotide, and a small molecule CD47 inhibitor. The company was founded by William A. Frazier and Jeffrey S. Isenberg in 2006 and is headquartered in Brisbane, CA. | Presidente | 10/06/2011 |
SARmont LLC
SARmont LLC Drugstore ChainsRetail Trade SARmont LLC is a holding company, which engages in the provision medicinal chemistry designs and optimization services. It offers consulting service to support early analysis of potential assets for academic or early stage ventures. The company was founded on September 29, 2010 and is headquartered in St. Louis, MO. | Amministratore Delegato | - |
Triathlon Medical Venture Partners LLC
Triathlon Medical Venture Partners LLC Investment ManagersFinance Triathlon Medical Venture Partners LLC (Triathlon Medical Venture) is a venture capital firm founded in 2004 by Dennis Costello and John Rice. The firm is headquartered in Cincinnati, Ohio with additional offices in Indianapolis and Louisville. | Investitore di Private Equity | - |
Formazione di Randy H. Weiss
Southeast Missouri State University | Undergraduate Degree |
Washington University in St. Louis | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 5 |
---|---|
Triathlon Medical Venture Partners LLC
Triathlon Medical Venture Partners LLC Investment ManagersFinance Triathlon Medical Venture Partners LLC (Triathlon Medical Venture) is a venture capital firm founded in 2004 by Dennis Costello and John Rice. The firm is headquartered in Cincinnati, Ohio with additional offices in Indianapolis and Louisville. | Finance |
Arch Oncology, Inc.
Arch Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Arch Oncology, Inc. develops drugs for life-threatening disorders. Its products include anti-CD47 monoclonal antibody, CD47 antisense oligonucleotide, and a small molecule CD47 inhibitor. The company was founded by William A. Frazier and Jeffrey S. Isenberg in 2006 and is headquartered in Brisbane, CA. | Commercial Services |
SARmont LLC
SARmont LLC Drugstore ChainsRetail Trade SARmont LLC is a holding company, which engages in the provision medicinal chemistry designs and optimization services. It offers consulting service to support early analysis of potential assets for academic or early stage ventures. The company was founded on September 29, 2010 and is headquartered in St. Louis, MO. | Retail Trade |
Cardialen, Inc.
Cardialen, Inc. Medical SpecialtiesHealth Technology Cardialen, Inc. develops medical devices. It offers pain-free cardio version therapy for atrial fibrillation (AF) using low-energy implantable atrial cardioverters. The firm develops and commercializes these as an independent specialist, to address major needs in atrial fibrillation management, achieve improved outcomes and reduce the risk of stroke, heart failure and high healthcare costs associated with atrial fibrillation. The company's products comprise implantable low-energy pain-free atrial cardioverters and cardiac leads and defibrillator equipment. Its products are used for the treatment of atrial and ventricular arrhythmias. Cardialen was founded in 2008 by D. Graeme Thomas, Randy H. Weiss and Igor R. Efimov and is headquartered in St. Louis, MO. | Health Technology |
Euclises Pharmaceuticals, Inc.
Euclises Pharmaceuticals, Inc. Hospital/Nursing ManagementHealth Services Euclises Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm develops a portfolio of COX-2 inhibitors optimized for cancer treatment based on its proprietary Euclicoxib platform and is in the process of selecting a lead clinical development candidate. The company was founded by John J. Talley in 2011 and is headquartered in St. Louis, MO. | Health Services |
- Borsa valori
- Insiders
- Randy H. Weiss